Table 2.

Decrease in DAS28 and components at follow-up compared to baseline for each individual patient

Decrease compared to baseline	LORA patients	YORA patients
6 months, mean (SD)	n=315	n=443
DAS28	1.6 (1.7)	1.5 (1.5)
Swollen joint count (0–28)	3.9 (5.1)	3.9 (4.8)
Tender joint count (0–28)	4.1 (6.7)	4.0 (6.7)
ESR mm/h	9.3 (23.0)	8.0 (16.1)
Patient global assessment (0–10)	2.1 (3.4)	1.8 (3.1)
12 months, mean (SD)	n=280	n=398
DAS28	1.9 (1.8)	1.9 (1.7)
Swollen joint count (0–28)	4.3 (5.2)	4.3 (5.1)
Tender joint count (0–28)	4.8 (6.9)	4.8 (6.9)
ESR mm/h	11.8 (23.5)	10.3 (17.8)
Patient global assessment (0–10)	2.2 (3.3)	2.2 (3.3)
18 months, mean (SD)	n=239	n=352
DAS28	1.9 (1.8)	1.8 (1.7)
Swollen joint count (0–28)	4.3 (5.3)	4.0 (5.4)
Tender joint count (0–28)	4.8 (7.0)	4.5 (6.8)
ESR mm/h	12.5 (23.1)	10.2 (17.8)
Patient global assessment (0–10)	2.3 (3.3)	2.2 (3.3)
24 months, mean (SD)	n=208	n=301
DAS28	2.3 (1.8)	1.9 (1.7)
Swollen joint count (0–28)	5.1 (5.5)	4.5 (5.3)
Tender joint count (0–28)	6.0 (7.3)	4.9 (7.5)
ESR mm/h	15.7 (25.4)	10.9 (18.7)
Patient global assessment (0–10)	2.5 (3.3)	2.0 (3.2)

SD standard deviation